The $110m venture financing of Aidoc Medical was the Medical devices industry’s top cross border venture financing deal as total deals worth $604.4m were announced globally in June 2022, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 43.7% over the previous month of $420.48m and a drop of 44.04% when compared with the last 12-month average, which stood at $1.08bn.
Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $176.2m. At the country level, the US topped the list in terms of deal value at $176.2m.
In terms of volumes, Europe emerged as the top region for Medical devices industry cross border venture financing deals globally, followed by North America and then Asia-Pacific.
The top country in terms of cross border venture financing deals activity in June 2022 was the US with eight deals, followed by the Israel with three and China with three.
In 2022, as of June, Medical devices cross border venture financing deals worth $4.83bn were announced globally, marking a decrease of 36.4% year on year.
Medical devices industry cross border venture financing deals in June 2022: Top deals
The top five Medical devices industry cross border venture financing deals accounted for 59.6% of the overall value during June 2022.
The combined value of the top five Medical devices cross border venture financing deals stood at $360m, against the overall value of $604.4m recorded for the month.
The top five Medical devices industry cross border venture financing deals of June 2022 tracked by GlobalData were:
1) Alpha Intelligence Capital,CDIB Capital and TCMI $110m venture financing deal with Aidoc Medical
2) The $80m venture financing of Proximie by Advent Life Sciences,British Patient Capital,Eight Roads Ventures,Emerson Collective,F Prime Capital,Global ventures,Maverick Ventures Israel,Minderoo Foundation,Mubadala Investment,Questa Capital Management and SoftBank Vision Fund 2
3) B Capital Group,Bohai Harvest RST (Shanghai) Equity Investment Fund,Bold Capital Partners,Pavilion Capital,Qiming Venture Partners and Warburg Pincus $60m venture financing deal with InSilico Medicine
4) The $60m venture financing of Aerin Medical by Ally Bridge Group,KCK Group,Orbimed Advisors and Questa Capital Management
5) Bristol-Myers Squibb,LifeForce Capital Management,Magnetic Ventures,Northpond Ventures and Taiho Ventures $50m venture financing deal with Transition Bio
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.